{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:18:33Z","timestamp":1771834713275,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rmed.2026.108685","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:46:26Z","timestamp":1770104786000},"page":"108685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of chronic obstructive pulmonary disease on cardiovascular outcomes and mortality benefits of sodium glucose co-transporter inhibitors in heart failure patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8526-4502","authenticated-orcid":false,"given":"Rohab","family":"Sohail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaraq Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridda","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakhar","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1215-9187","authenticated-orcid":false,"given":"Vyom","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Alberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Georgy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Dhand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4677-5461","authenticated-orcid":false,"given":"Andrei","family":"Feldiorean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0243-9035","authenticated-orcid":false,"given":"Seemab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4753-3591","authenticated-orcid":false,"given":"Sana","family":"Murtaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Nazeer","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmed.2026.108685_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cardfail.2021.12.017","article-title":"Economic issues in heart failure in the United States","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J. Card. Fail."},{"issue":"8","key":"10.1016\/j.rmed.2026.108685_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.108685_bib3","article-title":"The association between COPD and heart failure risk: a review","volume":"305","author":"De Miguel-D\u00edez","year":"2013","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"12","key":"10.1016\/j.rmed.2026.108685_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.rmed.2026.108685_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.rmed.2026.108685_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.rmed.2026.108685_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108685_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ejhf.2083","article-title":"Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA\u2010HF","volume":"23","author":"Dewan","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.rmed.2026.108685_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure","volume":"50","author":"Fonarow","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2026.108685_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109837","article-title":"Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease","volume":"186","author":"Anker","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"11","key":"10.1016\/j.rmed.2026.108685_bib11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ejhf.3000","article-title":"Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER","volume":"25","author":"Butt","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"23","key":"10.1016\/j.rmed.2026.108685_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1053\/euhj.2002.3255","article-title":"Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population","volume":"23","author":"Hobbs","year":"2002","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108685_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2026.108685_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2026.108685_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.rmed.2026.108685_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk\u2010of\u2010bias VISualization (robvis): an R package and shiny web app for visualizing risk\u2010of\u2010bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.rmed.2026.108685_bib17","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"12","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.rmed.2026.108685_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.rmed.2026.108685_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7651","key":"10.1016\/j.rmed.2026.108685_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.rmed.2026.108685_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurjhf\/hfp148","article-title":"The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease","volume":"11","author":"Boudestein","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.rmed.2026.108685_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.rmed.2026.108685_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.rmed.2026.108685_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.00044411","article-title":"Unrecognised ventricular dysfunction in COPD","volume":"39","author":"Macchia","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2026.108685_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2796.2008.01975.x","article-title":"Chronic obstructive pulmonary disease in patients admitted with heart failure","volume":"264","author":"Iversen","year":"2008","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.rmed.2026.108685_bib26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","article-title":"Heart failure and chronic obstructive pulmonary disease: an ignored combination?","volume":"8","author":"Rutten","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.rmed.2026.108685_bib27","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease","volume":"2016","author":"Salpeter","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"18","key":"10.1016\/j.rmed.2026.108685_bib28","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2026.108685_bib29","article-title":"Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD","volume":"177","author":"Poldermans","year":"2009","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2026.108685_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193143","article-title":"Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the EpiChron cohort","volume":"13","author":"Divo","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2026.108685_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2012.10.029","article-title":"Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)","volume":"165","author":"Mentz","year":"2013","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108685_bib32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.108685_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfp001","article-title":"Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.rmed.2026.108685_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108685_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCHEARTFAILURE.112.000265","article-title":"Do countries or hospitals with longer Hospital stays for acute heart failure have lower readmission rates?: findings from ASCEND-HF","volume":"6","author":"Eapen","year":"2013","journal-title":"Circ. Heart Fail."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:51:27Z","timestamp":1771833087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S0954611126000533"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108685","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of chronic obstructive pulmonary disease on cardiovascular outcomes and mortality benefits of sodium glucose co-transporter inhibitors in heart failure patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108685"}}